Is Cardiol Therapeutics financially healthy?
Yes
Cardiol Therapeutics could pay off all its debt with 0.6 years of earnings.
The numbers behind it
Net debt / EBITDA0.6 years
Cash vs. debt$21M vs. $125,523
Current ratio4.2×Short-term assets for each $1 of bills due within a year
How we decide
We measure debt in years of earnings (net debt / EBITDA): under 1 is very comfortable, 1 to 3 is manageable, above 3 is heavy. A company that earns less than 3 times its interest bill also counts as weak.
More questions about Cardiol Therapeutics
Data as of Nov 13, 2026.